Clinical trial Recruiting at 2 sites Interventional Ages 18 to 89

Personalized treatment to help people with cancer quit smoking and live longer

Official title: Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients

Run by Washington University School of Medicine · NCT07166120 · Data updated 2026-11-12

We will test whether personalized tobacco treatment using clinical, genetic, and biomarker information helps cancer patients who smoke quit and use cessation medications more than usual care.

More Smoking trials

Quick facts

Study typeInterventional
Ages18 Years to 89 Years
SexAll
Enrollment132 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations2 sites (St Louis, Missouri and 1 other locations)
StatusRecruiting
StartedSeptember 11, 2025
Main results expectedMarch 31, 2027
Study endsSeptember 30, 2027
Registry record updatedOctober 23, 2026
Trial IDNCT07166120 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult oncology clinic patients aged 18 to 89 who currently smoke about five or more cigarettes per day, can speak English, and are willing to consider medication to help reduce craving or smoking.

Probably not a fit

People already using smoking-cessation medication, those with contraindications to combination nicotine replacement therapy or varenicline (including pregnancy or certain cardiac problems), non-English speakers, or those unwilling to try medications may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multilevel precision tobacco treatment program (PrecisionTx-Onc) that gives personalized risk, benefit, and medication recommendations to clinicians and patients using clinical, genetic, and biomarker data. The intervention is compared to usual care in a 2-arm cluster randomized trial of 16 clinicians and about 96 patients (roughly six patients per clinician) with 1:1 allocation. Primary outcomes include patient receipt of tobacco treatment, medication use, and smoking abstinence measured at six months, along with mechanistic and implementation outcomes. The study is embedded in oncology/hematology clinics and was developed with input from both patients and providers.

Why it matters

Potential benefit: If successful, patients could get better-matched cessation medications and more clinician support, increasing quit rates and potentially improving survival.

How similar studies have gone: Some prior work suggests precision-guided smoking treatments can improve medication matching and quit outcomes, but applying a multilevel precision intervention specifically in oncology clinics is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Eligibility Criteria for Clinicians:

* Clinician from participating oncology/hematology clinic
* At least 18 years of age
* Can speak and understand English

Inclusion Criteria for Patients:

* Patient at participating clinic
* Age 18-89 years
* Current smoking (average cigarettes per day ≥5)
* Can speak and understand English
* Willing to consider medication to help reduce craving or smoking such as nicotine patch, lozenge, or varenicline

Exclusion Criteria for Patients:

* Active use of smoking cessation medication (within the past 30 days)
* Receipt of smoking cessation medication or prescription for smoking cessation medication (within the past 30 days)
* Having a contradiction for cNRT or varenicline (allergic reactions, current cardiac problems, pregnancy)
* Patients who were deemed by the investigator to be ineligible for participation in the trial

Where it's running

  • John Cochran Veteran's Affairs Medical Center
    St Louis, Missouri, United States
    Recruiting
  • Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Li-Shiun Chen, ScD, M.D., MPH — Washington University School of Medicine
  • Study coordinator: Li-Shiun Chen, ScD, M.D., MPH
  • Email: li-shiun@wustl.edu
  • Phone: 314-362-3932

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.